You Searched For "cipla gilead" and got 20 results
Sort By:
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
The EUA is based on available data from two global clinical trials – US National Institute for All…
PTI
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
Cipla launches generic remdesivir for COVID-19 patients
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
Top stock movers — Tata Motors, SBI Cards, Cochin Shipyard, Zydus Cadila, Cipla, Dr Reddy’s, MphasiS, and others
Indian stock market indices opened on a higher note on Friday, tracking gains in index majors HDFC …
Top stocks to watch — Cipla, Zydus Cadila, Dr Reddy Laboratories, Tech Mahindra, Avenue Supermarts, Cochin Shipyard, and others
Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Friday. T…
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
Wanted! American asks for ‘Made in India’ hepatitis drug for just 1% of its cost
Know what he planned to secure the drug for US citizens and hurdles involved in it. But there was …
COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir
This comes a day after the Drug Controller General of India (DCGI), considering the emergency and u…
PTI
Cipla shares gain over 3 pc as co launches generic remdesivir for COVID-19 patients
Remdesivir is the only USFDA-approved EUA for treatment for adult and paediatric patients hospitali…
PTI
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for rest…
PTI
These are the companies manufacturing COVID-19 drug Remdesivir in India
The agreements allow these companies to manufacture remdesivir for distribution in 127 count…
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500— here’s why
Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…
Remdesivir, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…